Andreas Varkaris

Assistant Professor in Medicine · Harvard Medical School · company speakers →

Dr. Varkaris is a physician scientist at the Mass General Cancer Center and a dedicated member of the Termeer Center for Targeted Therapies. His career has been marked by a dual commitment to direct patient care and pioneering translational research. Half of his efforts are devoted to administering early clinical trials of investigational agents targeting growth factor receptor signaling (FGFR2, PIK3CA and KRAS) , while the remaining time is focused on unraveling mechanisms of resistance to these agents and developing rational combination therapies that may benefit patients.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

RAS-Targeted Drug Development Summit

8 September 2026 Boston, United States “Is Perfect Selectivity Necessary? Rethinking KRAS Targeting in the Era of Resistance”

Sourcing speakers for your event?

Browse the speaker directory →